(Bigstock image) as the U.S. opioid epidemic rages on, the need for positive alternative pain drugs is...
at the 2017 VMworld conference in Las Vegas, Moffitt melanoma middle CTO Tom Hull spoke with TechRepublic...
For years, we economists have claimed to have a miracle treatment for heavy traffic. It’s “congestion pricing”: can charge drivers greater to make use of roads and bridges during the busiest instances, and clogged roadways will solve overnight. Now, finally, expertise can make that miracle a truth. With apps, GPS and other...
Former 500 Startups accelerator company Pluto AI is announcing $ 2.1 million in fundraising nowadays from Fall Line Capital,...
Terry Beasley can barely get away from bed. He keeps an ice p.c. on his head and...
Spectrum pharmaceuticals Inc. SPPI, -5.forty six% mentioned Wednesday that an food and Drug Administration advisory committee voted that biotechnology firm’s cancer remedy, Qapzola, did not show vast proof of a treatment effect over placebo. the company stated the FDA just isn’t certain to follow the committee’s suggestion, when it makes its remaining...
the patron Product security commission has at last weighed in on the Galaxy observe 7 debacle, issuing...
Clovis Oncology Inc. CLVS, +27.24% shares ticked larger after hours Tuesday following an important bounce within the common session because the food and Drug Administration usual a advertising and marketing utility for the corporate’s ovarian cancer remedy and granted it a priority overview course of. Clovis shares developed 1% to $ 23.25...
KaloBios pharmaceuticals Inc., the drug maker formerly run by using Martin Shkreli, said Friday it emerged from bankruptcy. the corporate emerged with exit equity financing of $ 11 million, which is along with the $ three million debtor-in-possession financing it acquired in may. KaloBios said it obtained the rights to advance benznidazole...
Sophiris Bio Inc. SPHS, +8.33% shares surged in the extended session Thursday after the tiny biotech’s prostate most cancers remedy showed promising ends up in a mid-stage medical learn about. Sophiris shares rallied 74% to $ 2.04 on heavy volume after hours. the company said its remedy topsalysin showed an ability to...
Anavex existence Sciences Corp.’s stock AVXL, -2.seventy four% surged 7.1% in premarket exchange Friday, after the biopharmaceutical firm said its Alzheimer treatment was once granted orphan drug designation with the aid of the meals and Drug Administration. Orphan drug designation offers sponsors for therapies of uncommon ailments with development and business incentives....
Amgen Inc. AMGN, +1.13% shares ticked up somewhat in the extended session Thursday after the biotech company stated the food and Drug Administration licensed its new ldl cholesterol therapy. Amgen shares rose zero.5% to $ 156.fifty six. the company said the therapy, Repatha, lowers “unhealthy” ldl cholesterol through blocking off a protein...
Facebook
Twitter
Instagram
Google+
LinkedIn
RSS